Literature DB >> 12183773

Long-term results of infrageniculate bypass grafting using all-autogenous composite vein.

Michael A Curi1, Christopher L Skelly, David H Woo, Tina R Desai, Daniel Katz, James F McKinsey, Hisham S Bassiouny, Bruce L Gewertz, Lewis B Schwartz.   

Abstract

Infrageniculate (below-knee) bypass using all-autogenous composite vein requires multiple incisions, venovenostomy, and prolonged operating time. The purpose of this study was to evaluate the long-term results of this procedure, with comparisons to grafts created from single-segment greater saphenous vein (GSV) or polytetrafluoroethylene (PTFE). A total of 362 consecutive infrainguinal bypass grafts with infrageniculate distal target arteries were created in 283 patients in a single institution between January 1995 and December 2000. Comorbid conditions were common, including diabetes (58%), coronary artery disease (56%), prior lower extremity revascularization (41%), end-stage renal failure (20%), and prior coronary artery bypass grafting (18%). The indication for revascularization was limb salvage in 93% of cases. The grafts were constructed from single segments of GSV (n = 239), from two or more vein segments resulting in an all-autogenous composite graft (n = 61), or from PTFE (n = 62). All-autogenous composite grafts were constructed using segments of ipsilateral or contralateral GSV (n = 49), upper extremity vein (n = 23), superficial femoral vein (n = 7), or lesser saphenous vein (n = 5). Infrageniculate all-autogenous composite vein grafts exhibited similar long-term results to those of GSV grafts, and far superior results to those of PTFE grafts. For patients with available autogenous segments, the all-autogenous composite vein graft is the conduit of choice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183773     DOI: 10.1007/s10016-001-0266-6

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Ten years after arterial bypass surgery for claudication: venous bypass is the primary procedure for TASC C and D lesions.

Authors:  Thomas Eugster; Regula Marti; Lorenz Gurke; Peter Stierli
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

2.  Is atherectomy the best first-line therapy for limb salvage in patients with critical limb ischemia?

Authors:  Gabriel Loor; Christopher L Skelly; Carl-Magnus Wahlgren; Hisham S Bassiouny; Giancarlo Piano; Wael Shaalan; Tina R Desai
Journal:  Vasc Endovascular Surg       Date:  2009-07-29       Impact factor: 1.089

3.  Comprehensive Assessment of Current Management Strategies for Patients With Diabetes and Chronic Limb-Threatening Ischemia.

Authors:  Shirli Tay; Sami Abdulnabi; Omar Saffaf; Nikolai Harroun; Chao Yang; Clay F Semenkovich; Mohamed A Zayed
Journal:  Clin Diabetes       Date:  2021-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.